Bivalent nanovaccine MntC-rePO@LS conffers efective protections against Pseudomonas aeruginosa and Staphylococcus aureus
1School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing
2Department of Microbiology and Biochemical Pharamacy, National Engineering Research Center of Immunological Products, College of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University), Chongqing
3Chongqing Yuanlun Biotechnology Co., Ltd. Chongqing
4Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China
收起